These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 33553660)

  • 1. Eradication of hepatitis C virus with direct-acting antivirals improves glycemic control in diabetes: A multicenter study.
    Takahashi H; Nakahara T; Kogiso T; Imajo K; Kessoku T; Kawaguchi T; Ide T; Kawanaka M; Hyogo H; Fujii H; Ono M; Kamada Y; Sumida Y; Anzai K; Shimizu M; Torimura T; Nakajima A; Tokushige K; Chayama K; Eguchi Y;
    JGH Open; 2021 Feb; 5(2):228-234. PubMed ID: 33553660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement in Glycemic Control of Type 2 Diabetes After Successful Treatment of Hepatitis C Virus.
    Hum J; Jou JH; Green PK; Berry K; Lundblad J; Hettinger BD; Chang M; Ioannou GN
    Diabetes Care; 2017 Sep; 40(9):1173-1180. PubMed ID: 28659309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct-acting antiviral agents decrease haemoglobin A1c level in patients with diabetes infected with hepatitis C virus: A systematic review & meta-analysis.
    Lapumnuaypol K; Pisarcik D; Putthapiban P; Sukhumthammarat W; Wijarnpreecha K; Thongprayoon C; Ungprasert P
    Indian J Med Res; 2020 Dec; 152(6):562-567. PubMed ID: 34145095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of treatment of hepatitis C with direct-acting antiviral agents on glycaemic control in diabetic patients: An updated systematic review and meta-analysis.
    Chen B; Iqbal U; Desai SK; Gries J; Verheyen E; Xie M; El Halabi M; Gaines S; Weisberg I
    J Viral Hepat; 2024 Jul; ():. PubMed ID: 39046172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic syndrome does not affect sustained virologic response of direct-acting antivirals while hepatitis C clearance improves hemoglobin A1c.
    Dong TS; Aby ES; Benhammou JN; Kawamoto J; Han SH; May FP; Pisegna JR
    World J Hepatol; 2018 Sep; 10(9):612-621. PubMed ID: 30310539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycemic Control after Initiating Direct-Acting Antiviral Agents in Patients with Hepatitis C Virus and Type 2 Diabetes Mellitus Using the United States Integrated Healthcare System.
    Wong AH; Sie J; Chen A; Gunawan B; Chung J; Rashid N
    J Res Pharm Pract; 2020; 9(1):16-23. PubMed ID: 32489956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus eradication by direct-acting antiviral agents improves carotid atherosclerosis in patients with severe liver fibrosis.
    Petta S; Adinolfi LE; Fracanzani AL; Rini F; Caldarella R; Calvaruso V; Cammà C; Ciaccio M; Di Marco V; Grimaudo S; Licata A; Marrone A; Nevola R; Pipitone RM; Pinto A; Rinaldi L; Torres D; Tuttolomondo A; Valenti L; Fargion S; Craxì A
    J Hepatol; 2018 Jul; 69(1):18-24. PubMed ID: 29505844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C Virus Eradication with New Interferon-Free Treatment Improves Metabolic Profile in Hepatitis C Virus-Related Liver Transplant Recipients.
    Beig J; Orr D; Harrison B; Gane E
    Liver Transpl; 2018 Aug; 24(8):1031-1039. PubMed ID: 29577581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Over time evaluation of glycaemic control in direct-acting antiviral-treated hepatitis C virus/diabetic individuals with chronic hepatitis or with cirrhosis.
    Cacciola I; Russo G; Filomia R; Pitrone C; Caccamo G; Giandalia A; Alibrandi A; Stella Franzè M; Porcari S; Maimone S; Saitta C; Squadrito G; Raimondo G
    Liver Int; 2021 Sep; 41(9):2059-2067. PubMed ID: 33894103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver function following hepatitis C virus eradication by direct acting antivirals in patients with liver cirrhosis: data from the PITER cohort.
    Quaranta MG; Ferrigno L; Tata X; D'Angelo F; Coppola C; Ciancio A; Bruno SR; Loi M; Giorgini A; Margotti M; Cossiga V; Brancaccio G; Dallio M; De Siena M; Cannizzaro M; Cavalletto L; Massari M; Mazzitelli M; De Leo P; Laccabue D; Baiocchi L; Kondili LA
    BMC Infect Dis; 2021 May; 21(1):413. PubMed ID: 33947337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Review on Extrahepatic Manifestations of Chronic Hepatitis C Virus Infection and the Impact of Direct-Acting Antiviral Therapy.
    Mazzaro C; Quartuccio L; Adinolfi LE; Roccatello D; Pozzato G; Nevola R; Tonizzo M; Gitto S; Andreone P; Gattei V
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus clearance by direct-acting antiviral treatments and impact on insulin resistance in chronic hepatitis C patients.
    Adinolfi LE; Nevola R; Guerrera B; D'Alterio G; Marrone A; Giordano M; Rinaldi L
    J Gastroenterol Hepatol; 2018 Jul; 33(7):1379-1382. PubMed ID: 29228501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained Improvement in Type 2 Diabetes Mellitus is Common After Treatment of Hepatitis C Virus With Direct-acting Antiviral Therapy.
    Gilad A; Fricker ZP; Hsieh A; Thomas DD; Zahorian T; Nunes DP
    J Clin Gastroenterol; 2019 Sep; 53(8):616-620. PubMed ID: 30614943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Treatment with Direct Acting Antiviral Drugs on Glycemic Control in Patients with Hepatitis C and Diabetes Mellitus.
    Mada PK; Malus ME; Parvathaneni A; Chen B; Castano G; Adley S; Moore M; Hieda M; Alam MJ; Feldman M; King JW
    Int J Hepatol; 2020; 2020():6438753. PubMed ID: 32395351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of HCV eradication by direct-acting antivirals on the transition of precancerous hepatic nodules to HCC: A prospective observational study.
    Toyoda H; Kumada T; Tada T; Mizuno K; Sone Y; Akita T; Tanaka J; Johnson PJ
    Liver Int; 2019 Mar; 39(3):448-454. PubMed ID: 30312003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of hepatocellular carcinoma after hepatitis C virus eradication following direct-acting antiviral treatment: relationship with serum zinc.
    Ozeki I; Nakajima T; Suii H; Tatsumi R; Yamaguchi M; Arakawa T; Kuwata Y
    J Clin Biochem Nutr; 2020 May; 66(3):245-252. PubMed ID: 32523252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic and renal changes in patients with chronic hepatitis C infection after hepatitis C virus clearance by direct-acting antivirals.
    Nevola R; Rinaldi L; Zeni L; Sasso FC; Pafundi PC; Guerrera B; Marrone A; Giordano M; Adinolfi LE
    JGH Open; 2020 Aug; 4(4):713-721. PubMed ID: 32782961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case series evaluating the impact of Hepatitis C eradication using direct acting antivirals on primary biliary cholangitis-associated autoimmunity.
    Nguyen HH; Khathlan A; Fritzler MJ; Swain MG
    BMC Gastroenterol; 2018 Jun; 18(1):97. PubMed ID: 29940867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon- and ribavirin-free therapy with new direct acting antivirals (DAA) for chronic hepatitis C improves vascular endothelial function.
    Schmidt FP; Zimmermann T; Wenz T; Schnorbus B; Ostad MA; Feist C; Grambihler A; Schattenberg JM; Sprinzl MF; Münzel T; Galle PR
    Int J Cardiol; 2018 Nov; 271():296-300. PubMed ID: 30077529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of hepatitis C virus genotype-4 eradication following direct acting antivirals on liver stiffness measurement.
    Tag-Adeen M; Sabra AM; Akazawa Y; Ohnita K; Nakao K
    Hepat Med; 2017; 9():45-53. PubMed ID: 29062242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.